Fate Therapeutics Inc (NASDAQ:FATE)
| 28.34 BATS BZX Real-Time Price As of 10:43am ET |  -0.54 / -1.87%Today’s Change | 12.59 Today|||52-Week Range 29.20 | +44.81% Year-to-Date |
Latest FATE News | Press Releases
No recent news for Fate Therapeutics Inc.
Today’s Trading
| Previous close | 28.88 |
| Today’s open | 28.81 |
| Day’s range | 28.24 - 29.20 |
| Volume | 88,607 |
| Average volume (3 months) | 893,569 |
| Market cap | $2.2B |
Data as of 10:43am ET, 02/18/2020
Growth & Valuation
| Earnings growth (last year) | -16.19% |
| Earnings growth (this year) | -20.89% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +15.44% |
| P/E ratio | NM |
| Price/Sales | 152.11 |
| Price/Book | 11.64 |
Competitors
Data as of 10:44am ET, 02/18/2020
Financials
| Next reporting date | March 13, 2020 |
| EPS forecast (this quarter) | -$0.39 |
| Annual revenue (last year) | $4.7M |
| Annual profit (last year) | -$66.6M |
| Net profit margin | -1,405.02% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
